Shareholders
Shareholders

Marcelo Rubén Figueiras

Pharmaceutical entrepreneur and chairman of Laboratorios Richmond, the company he acquired in 1992.

Laboratorios Richmond

Value of known holdings
≈ 46.99B ARS
Companies valued
1 of 1

About the shareholder

Richmond describes his role in transforming the laboratory and local COVID-19 vaccine manufacturing. The company records Fortuna’s Entrepreneur of the Year recognition in 2021 and his inclusion among UBA’s notable bicentennial graduates. He holds an accounting degree from UBA. He completed Strategic Negotiation and Owner/President Management at Harvard and the Global CEO program at IAE, Universidad Austral.

Verified companies

Value of the stake
≈ 46.99B ARS

Stake included: 38.54% ·

As of Class A
Capital
38.54%
Voting rights
—

Source: Laboratorios Richmond · estructura accionaria al 30/09/2025 · Retrieved Sep 29, 2026

Capital stake × market capitalization in ARS. Only the latest disclosure per company is counted. Dates differ; this is not the owner’s total wealth.

Market-cap data retrieved

Capital ownership and voting rights are different measures. “—” means unavailable, not zero.

Sources: Laboratorios Richmond · Gobierno corporativo

A view of the market.
With full transparency.

Closing prices and daily history from BYMA Open Data. These are not real-time quotes.

Quote sourceBYMA Open DataLatest available sessionOct 02, 2026Last fetchedOct 3, 2026, 04:27 AM GMT-3CurrencyARSSettlementT+1 · 24hsCoverage133 / 258

Daily history is kept as supplied by BYMA. Symbols without data show no quote. Dates may differ between stocks. Corporate-action adjustments are not independently verified.

Financial data

Financial statements, multiples and estimates. Availability varies by instrument. Profiles and shareholders show their sources and dates.

Last fetched: Oct 03, 2026

La Plata is independent. Commercial data publication requires reviewing BYMA terms.